Discontinued — last reported Q4 '25
Oracle Interest Paid remained flat by 0.0% to $843.50M in Q1 2025 compared to the prior quarter. Year-over-year, this metric declined by 7.7%, from $913.75M to $843.50M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 8.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $2.41B | $2.74B | $3.25B | $3.66B | $3.37B |
| YoY Change | — | +13.6% | +18.8% | +12.5% | -7.7% |